Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

The 'reserved for issuance' of 54M must be wrong.

I just pointed out the possible difference a financing would be between $3 and $20+.

Without sponsors or paying partnerships AGN will eventually need money to run the Phase 2 Trials. (assumed 540k @ $20+)

It's time for hard work from the CEO / CSO / BoD members, etc., to bring the company value up Before raising money.

I agree there is NO reason to do it now. $2.4M on their books?

All Shareholders are already in full Ben Dover.
...GLTA...